• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 245


Intended Use: As a nutrient supplement in dairy products, margarine substitutes, and dairy products including yoghurt, cottage cheese, hard cheeses, milk drinks and substitute products at levels up to 50 micrograms per day
Basis: Scientific procedures
Notifier: NattoPharma ASA
Notifier Address: Lysaker Torg 5, PO Box 397 Lysaker, NO-1326 Lysaker, NORWAY
Date of filing: Apr 2, 2008
GRAS Notice (releasable information): GRN 245 (in PDF)
Date of closure: Jun 2, 2008
FDA's Letter: At notifier's request, FDA ceased to evaluate the notice